Search

everythinglearnresearchcommunity

for

Search:↓

The combination treatment reduced prostate size and improved testosterone deficiency symptoms but was less effective for sexual function.

Finasteride boosts morphine's pain relief, stops tolerance, and reduces withdrawal in rats.

The effect of GLP-1 RAs on erectile function is unclear and needs more research.

Ritlecitinib effectively maintains hair regrowth in alopecia areata patients.

Ritlecitinib effectively improves hair regrowth and physician satisfaction in severe alopecia areata over time.

Natural 5AR inhibitors effectively improve mild to moderate hair loss in men.

Methylation in specific gene region causes finasteride resistance in some BPH patients.

Specific mutations in a receptor cause facial abnormalities and hair loss.

Ritlecitinib is effective and safe for treating severe alopecia areata in people aged 12 and older.

A new method allows for controlled, long-lasting delivery of retinoic acid through the skin with fewer side effects.

Selective non-steroidal inhibitors of 5α-reductase type 1 can help treat DHT-related disorders.

Chloroquine and cinchonine relax rat blood vessels by affecting calcium channels, with chloroquine needing caution in heart patients.

Blocking androgen receptors early in life increases estrogen levels and reduces sexual motivation in male rats.

New pregnane derivatives were more effective than finasteride at inhibiting a key enzyme for male pattern baldness.

Sandalore® improves hair growth and quality in people with hair loss.

Morphine increases testosterone breakdown in the rat brain and spinal cord.

Combination therapy for BPH is more effective in certain men but may not be cost-effective due to minimal impact and potential side effects.

Ritlecitinib provides new treatment options for diverse alopecia areata patients.

Urotensin II increases growth and VEGF production in rat skin cells by turning on the Wnt-β-catenin pathway.

A new compound effectively inhibits human 5α-reductase 1.

Eplerenone, a mineralocorticoid receptor antagonist, was found to promote hair growth in human hair follicles.

Dutasteride works better than finasteride for preventing and treating prostate cancer.

Switching to ritlecitinib improves hair regrowth and well-being in severe alopecia areata patients.

Low testosterone and 5α-reductase inhibitors can harm men's metabolic and sexual health; testosterone therapy may help, but discussing 5α-RIs' side effects is important.

D-004 shows moderate antidepressant effects but is less effective than Sertraline and Imipramine.

The study created special nanoparticles that effectively deliver an anti-inflammatory drug to treat skin inflammation in psoriasis.

Prostaglandin D2 increases testosterone production in skin cells through a process involving reactive oxygen species, and antioxidants may help treat hair loss.

Neuroactive steroids affect cocaine's rewarding effects through the sigma1 receptor.

Botulinum Toxin Type A effectively treats various conditions with high patient satisfaction and minimal side effects.